You are here

Europe

AbbVie Pushing Hepatitis C Pipeline, But Is It Fast Enough?

Seeking Alpha

Wed, 04/29/15 - 09:57 am

Bullied in Norway, Merck Sees Sales of Blockbuster Dive

Bloomberg

Thu, 04/23/15 - 03:22 am

rheumatoid arthritis

Pluristem's Clinical Advisory Board Prepares Phase II Clinical Trials in Critical Limb Ischemia in Europe and Japan

Yahoo

Mon, 04/20/15 - 10:32 am

Pluristem Therapeutics

critical limb ischemia

Will This EU Approval Move the Needle for Amgen?

Investopedia

Tue, 04/7/15 - 11:20 am

colorectal cancer

Orexigen shares rise as Wall Street gives thumbs up to weight-loss drug's European approval

Yahoo/AP

Fri, 03/27/15 - 08:44 am

Orexigen says EU regulators approved its weight loss drug, which will be marketed as Mysimba

Yahoo/AP

Thu, 03/26/15 - 09:32 pm

Copy me: Europe shows U.S. a path to cheaper biotech drugs

Yahoo/Reuters

Fri, 03/6/15 - 07:54 am

Pfizer Inc. Wins European Commission Approval For New Prevenar 13 Indication

Bidness Etc.

Wed, 03/4/15 - 08:33 am

Bayer nabs new Eylea nod to help it toward 2015 sales target

Fierce Pharma

Fri, 02/27/15 - 06:59 pm

retinal vein occlusion

Sanofi diabetes drug Toujeo wins European green light

Yahoo/Reuters

Fri, 02/27/15 - 11:25 am

Novartis lung cancer drug gets EU recommendation

Yahoo/Reuters

Fri, 02/27/15 - 09:09 am

If Pfizer's Right, Hospira Biosimilar Gold Rush Begins This Week

Forbes

Mon, 02/16/15 - 11:55 am

autoimmune disease

Gilead agrees 41,000 eur hep-C drug price for 12 week treatment

Yahoo/Reuters

Thu, 02/12/15 - 02:06 pm

Gilead Sciences

Gilead expects big increase in Europeans treated with hep C drug

Yahoo/Reuters

Wed, 02/11/15 - 09:50 am

Gilead Sciences

Gilead faces challenge to European patent on pricey hep C drug

Yahoo/Reuters

Tue, 02/10/15 - 10:21 am

Gilead Sciences

Orexigen Provides Progress Update on Mysimba European Marketing Authorization

Yahoo

Mon, 02/9/15 - 06:16 pm

Aprea's Ovarian Cancer Drug Gains Orphan Drug Designation

Drug Discovery and Development

Mon, 01/26/15 - 09:42 am

EMA Recommends Hundreds of Drugs to be Suspended Over ‘Flawed Studies’

WSJ Pharmalot

Fri, 01/23/15 - 10:31 am

EC clears Boehringer Ingelheim's Ofev for idiopathic pulmonary fibrosis

First Word Pharma

Mon, 01/19/15 - 12:02 pm

Boehringer Ingelheim

idiopathic pulmonary fibrosis

AbbVie’s hepatitis C drug gets European approval for sale

Marketwatch

Fri, 01/16/15 - 08:45 am

Pages